1. A novel anti-CD22 scFv–apoptin fusion protein induces apoptosis in malignant B-cells
   Solmaz Agha Amiri et al, 2017, AMB Expr CrossRef
2. Local non-viral gene delivery of apoptin delays the onset of paresis in an experimental model of intramedullary spinal cord tumor
   W A Pennant et al, 2014, Spinal Cord CrossRef
3. null
   Claude Backendorf et al, 2014 CrossRef
4. Apoptins: selective anticancer agents
   Oscar M. Rollano Peñaloza et al, 2014, Trends in Molecular Medicine CrossRef
5. Viral genes as oncolytic agents for cancer therapy
   Shishir Kumar Gupta et al, 2015, Cell. Mol. Life Sci. CrossRef
6. The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment
   Encheng Yang et al, 2016, Cancer Cell Int CrossRef
7. Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death
   Jasmine Wyatt et al, 2019, Cancers CrossRef
8. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses
   Faith Howard et al, 2020, Nanomedicine CrossRef
9. Virus-esque nucleus-targeting nanoparticles deliver trojan plasmid for release of anti-tumor shuttle protein
   Suleixin Yang et al, 2020, Journal of Controlled Release CrossRef
10. Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems
    Waseem Akram Malla et al, 2020, Front. Cell Dev. Biol. CrossRef
11. null
    Faith Hannah Nutter Howard et al, 2022 CrossRef